ArticlesPricing

Products

See All Solutions →
By ProductEMARKETER PRO+Analyst Access Program
By Use CaseDetermine Market SizingDevelop StrategiesAllocate BudgetBenchmark PerformanceWin New BusinessDevelop Go-to-Market StrategyStay InformedThought LeadershipSee All Use Cases →
Advertising & Sponsorship
Boost your brand and generate demand with media programs.
Learn More →

Events & Resources

Learning Center
Read through guides, explore resource hubs, and sample our coverage.
Learn More →
Events
Register for an upcoming webinar and track which industry events our analysts attend.
Learn More →
Podcasts
Listen to our podcast, Behind the Numbers for the latest news and insights.
Learn More →

Topics

See All Topics →
Advertising & MarketingSocial MediaContent MarketingEmail MarketingVideoBrowse All →
Ecommerce & RetailEcommerce SalesMcommerceRetail SalesSocial CommerceBrowse All →
Financial ServicesBankingPaymentsFintechWealth ManagementBrowse All →
GeographiesAsia-PacificCentral & Eastern EuropeLatin AmericaMiddle East & AfricaNorth AmericaWestern Europe
HealthValue-Based CareDigital TherapeuticsTelehealthOnline PharmacyBrowse All →
TechnologyConnected Devices5GArtificial Intelligence (AI)Browse All →
More IndustriesReal EstateCustomer ExperienceB2BTravelSmall Business (SMB)Browse All →

Latest Articles

Explore our Research →

The big answers: EMARKETER Daily quiz

Article |
 Aug 21, 2025

Claire’s second bankruptcy signals deeper challenges for mall-based retailers

Article |
 Aug 21, 2025

ESPN’s evolution to a direct to consumer brand begins today

Article |
 Aug 21, 2025

Walmart hikes top- and bottom-line outlook even as tariff costs rise

Article |
 Aug 21, 2025

Marketers use genAI to customize video ads

Article |
 Aug 20, 2025

EHR giant Epic introduces new AI scribe capabilities for doctors

Article |
 Aug 20, 2025

Usage-based deals could reshape AI content monetization models

Article |
 Aug 20, 2025

Google bets Pixel’s future on AI with Gemini and Magic Cue

Article |
 Aug 20, 2025

Estée Lauder slumps in latest quarter, warns of $100 million tariff hit

Article |
 Aug 20, 2025

OOH spurs hike in awareness

Article |
 Aug 19, 2025
Browse All →

About

Our Story
Learn more about our mission and how EMARKETER came to be.
Learn More →
Our Clients
Key decision-makers share why they find EMARKETER so critical.
Learn More →
Our People
Take a look into our corporate culture and view our open roles.
Join the Team →
Our Methodology
Rigorous proprietary data vetting strips biases and produces superior insights.
Learn More →
Newsroom
See our latest press releases, news articles or download our press kit.
Learn More →
Contact Us
Speak to a member of our team to learn more about EMARKETER.
Contact Us →
EMARKETER

Elevance requests repayment from doctors for overprescribing Ozempic

Article by Rajiv Leventhal  |  Sep 17, 2024
Download
Elevance requests repayment from doctors for overprescribing Ozempic
Share
Topics
Digital Health
United States

The news: Health insurer Elevance Health is requesting over $1 million in repayments from healthcare providers for allegedly inappropriately prescribing Ozempic to their patients, according to a Bloomberg report.

Digging into the details: Elevance’s Anthem Blue Cross Blue Shield health plan contacted a small number of providers for their alleged excessive off-label prescribing of Ozempic.

  • For context, Ozempic is FDA-approved to treat type 2 diabetes but is commonly prescribed off-label for weight loss. Elevance said that Anthem only covers Ozempic for diabetes.

You've read 0 of 2 free articles this month.

Create an account for uninterrupted access to select articles.
Create a Free Account